ERBB2 and breast cancer: Metastasis to the central nervous system (both brain parenchymal and LMD) is more common among certain subtypes of breast cancer and occurs in almost 1 out of 3 patients with stage IV human epidermal growth factor receptor-2-positive (HER2-positive) or triple-negative breast cancer [21].